ES2060737T3 - Procedimiento de preparacion de un granulado farmaceutico. - Google Patents

Procedimiento de preparacion de un granulado farmaceutico.

Info

Publication number
ES2060737T3
ES2060737T3 ES89200430T ES89200430T ES2060737T3 ES 2060737 T3 ES2060737 T3 ES 2060737T3 ES 89200430 T ES89200430 T ES 89200430T ES 89200430 T ES89200430 T ES 89200430T ES 2060737 T3 ES2060737 T3 ES 2060737T3
Authority
ES
Spain
Prior art keywords
preparing
procedure
granulate
pharmaceutical granulate
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89200430T
Other languages
English (en)
Inventor
Margaretha Olthoff
Bernardus Leonardus Dijkgraaf
Piet Johannes Akkerboom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Europe BV
Original Assignee
Yamanouchi Europe BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Europe BV filed Critical Yamanouchi Europe BV
Application granted granted Critical
Publication of ES2060737T3 publication Critical patent/ES2060737T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN GRANULADO MOJADO ES PROPORCIONADO CONTENIENDO UNA SUSTANCIA TERAPEUTICAMENTE UTIL TENIENDO UNA SOLUBILIDAD AL AGUA DE 10% O MENOR Y CELULOSA MICROCRISTALINA O MICROFINA, O UNA MEZCLA DE AMBOS, CARACTERIZADO EN QUE LAS CANTIDADES SUSTANCIALES DE LIGANTES EN MOJADO SE ELUDEN. LA MEZCLAS DE PASTILLAS CON EL NUEVO GRANULADO POSEEN UN MODELO DE BUEN FLUJO Y PUEDEN SER COMPRIMIDAS EN TABLETAS QUE MUESTRAN UNA EXCELENTE CONDUCTA DE DESINTEGRACION.
ES89200430T 1988-02-25 1989-02-20 Procedimiento de preparacion de un granulado farmaceutico. Expired - Lifetime ES2060737T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88200346 1988-02-25

Publications (1)

Publication Number Publication Date
ES2060737T3 true ES2060737T3 (es) 1994-12-01

Family

ID=8199757

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89200430T Expired - Lifetime ES2060737T3 (es) 1988-02-25 1989-02-20 Procedimiento de preparacion de un granulado farmaceutico.

Country Status (17)

Country Link
US (1) US5085869A (es)
EP (1) EP0330284B1 (es)
JP (1) JP2939262B2 (es)
KR (1) KR0135289B1 (es)
CN (1) CN1048395C (es)
AT (1) ATE108996T1 (es)
AU (1) AU611999B2 (es)
CA (1) CA1338553C (es)
DE (1) DE68916983T2 (es)
DK (1) DK175306B1 (es)
ES (1) ES2060737T3 (es)
FI (1) FI100219B (es)
IE (1) IE69366B1 (es)
IL (1) IL89378A (es)
NO (1) NO178485C (es)
NZ (1) NZ228122A (es)
PT (1) PT89823B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
UA37214C2 (uk) * 1991-01-30 2001-05-15 Дзе Веллкам Фаундейшн Лімітед Таблетки, що диспергуються у воді, та спосіб їх виготовлення
JP3069458B2 (ja) * 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
ES2111659T3 (es) * 1992-03-11 1998-03-16 Asta Medica Ag Comprimidos, granulados y nodulos con alto contenido en sustancias activas para formas de administracion solidas de alta concentracion.
JP2964195B2 (ja) * 1992-04-28 1999-10-18 エスエス製薬株式会社 ピロキシカム錠及びその製造法
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
CA2159419C (en) * 1994-10-17 2006-07-04 Pieter De Haan Solid pharmaceutical composition comprising an excipient capable of binding water
SE504902C2 (sv) * 1994-11-02 1997-05-26 Diabact Ab Beredning för påvisande av Helicobacter pylori i magsäcken
ZA961018B (en) * 1995-02-08 1997-08-08 Yamanouchi Europ Bv Oral dosage-forms containing a beta-lactam antibiotic.
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
EP0912169A2 (en) * 1996-07-16 1999-05-06 Gist-Brocades B.V. $g(b)-LACTAM GRANULES FREE OF ORGANIC SOLVENTS
DK0948318T3 (da) * 1996-08-14 2004-06-28 Yamanouchi Europ Bv Granulater omfattende en vandoplöselig forbindelse og cellulose
AU1970797A (en) * 1997-02-25 1998-09-09 Procter & Gamble Company, The Wet granulating method
US5785995A (en) * 1997-04-11 1998-07-28 Upsher-Smith Laboratories, Inc. Pharmaceutical tablet of amiodarone salt
GB9720061D0 (en) * 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
WO1999018965A1 (en) * 1997-10-10 1999-04-22 Yamanouchi Europe B.V. Oral compositions containing a cephalosporin antibiotic
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
NZ511938A (en) * 1998-12-23 2004-02-27 Novartis Ag Use of AT-1 receptor antagonist or treating diseases associated with an increase of AT-1 receptor
EA003052B1 (ru) 1999-07-27 2002-12-26 Балканфарма Холдинг АД Антиаритмическое лекарственное средство
AR028253A1 (es) * 2000-03-16 2003-04-30 Pfizer Prod Inc Inhibidores de la glucogeno fosforilasa
CA2437375A1 (en) * 2001-02-05 2002-08-15 R.P. Scherer Technologies, Inc. Methods and compositions for reducing the taste of pharmaceutically active agents
RU2181290C1 (ru) * 2001-04-26 2002-04-20 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция, обладающая антимикробным действием
CN1688291A (zh) * 2002-02-01 2005-10-26 辉瑞产品公司 含有固体药物分散体的即刻释放剂型
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
RU2237478C2 (ru) * 2002-12-25 2004-10-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Антимикробная фармацевтическая композиция
US20050008691A1 (en) * 2003-05-14 2005-01-13 Arturo Siles Ortega Bicalutamide compositions
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
FR2991179B1 (fr) 2012-06-01 2016-11-11 Ceva Sante Animale Compositions veterinaires orales appetentes
US20190167592A1 (en) * 2016-07-13 2019-06-06 Gangwal Chemicals Private Limited Process for directly compressible co-processed excipient for modified release application

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5438167B2 (es) * 1974-04-27 1979-11-19
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2058565B (en) * 1979-09-21 1983-12-07 Leo Pharm Prod Ltd Layer tablets
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
NZ199931A (en) * 1981-03-13 1985-02-28 Lilly Co Eli Method for formulating medicated animal feed premix comprising a synthetic drug
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
EP0080862B1 (en) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
JPS59101423A (ja) * 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
JPS6097919A (ja) * 1983-11-01 1985-05-31 Furointo Sangyo Kk 圧縮成形用賦形剤の製造方法
NL8400911A (nl) * 1984-03-22 1985-10-16 Dagra Nv Werkwijze ter bereiding van een farmaceutische toedieningsvorm die tetracycline of doxycyclinezouten bevat.
DE3681348D1 (de) * 1985-06-11 1991-10-17 Teijin Ltd Oral-arzneizubereitung mit retardwirkung.
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
GB8618811D0 (en) * 1986-08-01 1986-09-10 Approved Prescription Services Sustained release ibuprofen formulation
ES2061623T3 (es) * 1987-03-02 1994-12-16 Brocades Pharma Bv Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds

Also Published As

Publication number Publication date
NO890789L (no) 1989-08-28
FI890884L (fi) 1989-08-26
AU611999B2 (en) 1991-06-27
KR0135289B1 (ko) 1998-04-23
DK86389D0 (da) 1989-02-24
CN1048395C (zh) 2000-01-19
EP0330284A3 (en) 1990-11-07
CA1338553C (en) 1996-08-27
KR900012603A (ko) 1990-09-01
FI890884A0 (fi) 1989-02-24
DE68916983D1 (de) 1994-09-01
EP0330284B1 (en) 1994-07-27
JPH023606A (ja) 1990-01-09
NO178485C (no) 1996-04-10
NO890789D0 (no) 1989-02-24
PT89823A (pt) 1989-10-04
IL89378A0 (en) 1989-09-10
FI100219B (fi) 1997-10-31
CN1035433A (zh) 1989-09-13
DE68916983T2 (de) 1995-01-19
NZ228122A (en) 1991-04-26
AU3015889A (en) 1989-08-31
DK175306B1 (da) 2004-08-16
IE69366B1 (en) 1996-09-04
IL89378A (en) 1993-01-31
NO178485B (no) 1996-01-02
ATE108996T1 (de) 1994-08-15
JP2939262B2 (ja) 1999-08-25
DK86389A (da) 1989-08-26
IE890545L (en) 1989-08-25
US5085869A (en) 1992-02-04
PT89823B (pt) 1994-04-29
EP0330284A2 (en) 1989-08-30

Similar Documents

Publication Publication Date Title
DK86389A (da) Farmaceutisk granulat
UA42745C2 (uk) Спосіб виготовлення таблеток, які містять пароксетин, та таблетка, яка містить пароксетин
ES2064112T3 (es) Composicion farmaceutica para suspension rapida en agua.
ES2057409T3 (es) Formas de dosificacion de disolucion rapida.
ES2032755T3 (es) Medicamentos conteniendo hexadecil-fosfocolina con efecto antitumoral.
DE69727825D1 (de) Gleichzeitig hergestellte zusammensetzung von mikrokristalliner cellulose und calciumcarbonat
DE69940674D1 (de) Orale verabreichung von adenosin analogen
GR3017161T3 (en) Multi-fractionable tablet structure.
ES2077757T5 (es) Preparacion farmaceutica solida con disolucion rapida que contiene la n-acetilcisteina.
DK214689A (da) Farmaceutiske midler
DK624287A (da) Komprimeret tablet eller kapsel
ATE239709T1 (de) Racemisches huperzin a
DE3677395D1 (de) Pharmazeutische zusammensetzung aus guar-gummi und anderen antiacida zum schutz der oeso-gastro-duodenalen schleimhaut.
MX9100246A (es) Preparacion farmaceutica en forma de tabletas o grageas que contienen sulcralfato y procedimiento para su preparacion
ES2010466A6 (es) Formas de administracion solidas, de rapida desintegracion.
SE8703889D0 (sv) Sustained release pharmaceutical compositions
ES8402153A1 (es) Un procedimiento para preparar una composicion solida comprimida para la limpieza de dentaduras postizas.
JPS5566507A (en) Preparation of foamed tablet
DE3886371D1 (de) Herstellung des hblv-virus in der hsb-2 zell-linie.
MY101916A (en) Etoposide oral dosage form.
DK161564C (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende det fibrinolytiske middel urokinase og diffusionsfaktoren hyaluronidase
ES2160117T3 (es) Composicion farmaceutica antitumoral a base de carboplatino, y su procedimiento de produccion.
ES283591U (es) Una tableta de dosificacion farmaceutica adecuada para administracion oral
IL79207A (en) Geriatric pharmaceutical compositions containing terguride for treatment of cognitive and psychic disorders due to dopamine hypofunction
IT1173449B (it) Prodotto in pastiglie da usare nella eliminazione per via chimica della fuliggine da camini e condotti dei fumi